Cleviprex
Payments companies reported to CMS as associated with Cleviprex. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Cleviprex, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Cleviprex
These are the largest totals companies reported as associated with Cleviprex. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| David Rose | Tampa, FL | Neurology (Psychiatry & Neurology) | $210,859.39 |
| Dawn Meyer | San Diego, CA | Family | $153,410.16 |
| Fariborz Rezai | Livingston, NJ | Critical Care Medicine (Internal Medicine) | $108,482.43 |
| Sergio Bergese | Columbus, OH | Anesthesiology | $67,793.54 |
| Todd Horowitz | Delray Beach, FL | Anesthesiology | $64,374.46 |
| Edward Obrien | Urbana, IL | Anesthesiology | $54,475.15 |
| Michael Boss | Towson, MD | Anesthesiology | $36,524.58 |
| Aniel Majjhoo | Flint, MI | Vascular Neurology | $30,619.79 |
| Scott Brehaut | Clinton, NY | Family Medicine | $29,777.53 |
| Charles Pollack | Roswell, GA | Emergency Medicine | $29,506.00 |
Prescribed Cleviprex?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.